
GC33064
Luxeptinib
Also listed as CG-806 (Luxeptinib)
CG-806 (Luxeptinib) (CG-806) is an orally active, reversible, first-in-class, non-covalent and potent pan-FLT3/pan-BTK inhibitor· CG-806 (Luxeptinib) induces cell cycle arrest, apoptosis or autophagy in acute myeloid leukemia cells
ChemicalCAS1616428-23-9MW495.43FormulaC25H17F4N5O2
- CAS number
- 1616428-23-9
- Molecular weight
- 495.43
- Formula
- C25H17F4N5O2
- Solubility
- DMSO : 7·2 mg/mL (14·13 mM)
- InChIKey
- MWHHJYUHCZWSLS-UHFFFAOYSA-N
- Catalogue number
- GC33064
- Brand
- GLPBIO
Computed properties PubChem CID 118480924 · XLogP 3.6 · TPSA 98.9 Ų · H-bond donors 4
- XLogP
- 3.6
- TPSA
- 98.9 Ų
- H-bond donors
- 4
- H-bond acceptors
- 7
- Rotatable bonds
- 4
- Heavy atoms
- 36
SMILES CC1=CN=C(N1)C2=C3C(=C(C=C2)C4=C(C=C(C=C4)NC(=O)NC5=C(C=C(C=C5F)F)F)F)CNC3=O
Computed descriptors from PubChem (CID 118480924), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il